- Home
- TSBK vs INBX Comparison
TSBK vs INBX Comparison
Compare TSBK & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSBK
- INBX
- Stock Information
- Founded
- TSBK 1915
- INBX 2010
- Country
- TSBK United States
- INBX United States
- Employees
- TSBK N/A
- INBX N/A
- Industry
- TSBK Banks
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- TSBK Finance
- INBX Health Care
- Exchange
- TSBK Nasdaq
- INBX Nasdaq
- Market Cap
- TSBK 232.5M
- INBX 218.9M
- IPO Year
- TSBK 1998
- INBX 2020
- Fundamental
- Price
- TSBK $29.38
- INBX $13.49
- Analyst Decision
- TSBK
- INBX Hold
- Analyst Count
- TSBK 0
- INBX 1
- Target Price
- TSBK N/A
- INBX N/A
- AVG Volume (30 Days)
- TSBK 12.7K
- INBX 84.0K
- Earning Date
- TSBK 01-28-2025
- INBX 11-14-2024
- Dividend Yield
- TSBK 3.40%
- INBX N/A
- EPS Growth
- TSBK N/A
- INBX N/A
- EPS
- TSBK 3.01
- INBX 119.38
- Revenue
- TSBK $74,154,000.00
- INBX $1,568,000.00
- Revenue This Year
- TSBK N/A
- INBX N/A
- Revenue Next Year
- TSBK N/A
- INBX N/A
- P/E Ratio
- TSBK $9.76
- INBX $0.11
- Revenue Growth
- TSBK N/A
- INBX 19.24
- 52 Week Low
- TSBK $23.93
- INBX $10.80
- 52 Week High
- TSBK $33.98
- INBX $18.95
- Technical
- Relative Strength Index (RSI)
- TSBK 41.84
- INBX 40.15
- Support Level
- TSBK $27.57
- INBX $12.51
- Resistance Level
- TSBK $29.99
- INBX $14.86
- Average True Range (ATR)
- TSBK 0.64
- INBX 1.03
- MACD
- TSBK -0.00
- INBX -0.20
- Stochastic Oscillator
- TSBK 52.77
- INBX 22.69
About TSBK Timberland Bancorp Inc.
Timberland Bancorp Inc is a bank holding company. The bank offers a variety of services such as checking accounts, online and mobile banking, savings accounts, home loans, consumer loans, construction loans, business rewards, cash management, small business solutions, and business checking accounts among others. Company also offers loans to real estate, including residential and commercial / multi-family construction loans, one- to four-family residential loans, multi-family loans, commercial real estate loans and land loans. The company mainly operates in the United States.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.